The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Quadrivalent Human Papillomavirus Vaccine
Abstract
The lifetime risk of human papillomavirus (HPV) infection exceeds 50%. HPV infection causes >550,000 cases of cervical and anogenital cancer worldwide annually. Infection also causes precancerous lesions and genital warts. HPV types 16 and 18 cause approximately 70% of HPV-related cancers, and HPV types 6 and 11 cause approximately 90% of cases of genital warts. A quadrivalent vaccine for HPV types 6, 11, 16, and 18 (HPV 6/11/16/18) has been developed for prevention of cervical cancer, genital warts, and vulvar and vaginal precancerous lesions. Prophylactic vaccination of young women was 96%-100% effective in preventing HPV 6/11/16/18-related cervical and anogenital precancers and genital warts. Efficacy remained high for at least 5 years following vaccination. Postvaccination anti-HPV levels in adolescents were superior to those observed in women (the population in which efficacy was shown). Vaccination was generally well tolerated. The vaccine is licensed in >80 countries. It has been added to national vaccination programs, including that of the United States. Widespread use of HPV 6/11/16/18 vaccine is expected to greatly reduce the incidence of HPV-related cancers, precancers, and genital warts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
(2006) · PubMed · Cited by 3,378
Cancer Epidemiology and Prevention
(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Firminger, H. I. (1968) · Armed Forces Institute of Pathology eBooks · Cited by 3,044
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
Kreimer, A. R., Clifford, G. M., Boyle, P., & Franceschi, S. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0551 · Cited by 2,184
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,072
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa061741 · Cited by 2,055
Youth Risk Behavior Surveillance United States, 2015
Kann, L., McManus, T., Harris, W. A., Shanklin, S. L., Flint, K. H., Hawkins, J., Queen, B., Lowry, R., Olsen, E. O., Chyen, D., et al. (2016) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6506a1 · Cited by 2,036
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
Self-citation(1994) · PsycEXTRA Dataset · doi:10.1037/e546992006-001 · Cited by 1,714
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
Self-citationVilla, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
Self-citationHuman papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Chapter 2: The burden of HPV-related cancers
Parkin, D. M., & Bray, F. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.111 · Cited by 1,385
NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA
RICHART, R. M. (1967) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-196712000-00002 · Cited by 1,376
2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities
Wright, Jr. (2002) · JAMA · doi:10.1001/jama.287.16.2120 · Cited by 1,215
Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1111/j.1931-2393.2004.tb00002.x · Cited by 1,153
Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R., & Schiller, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12180 · Cited by 1,110
Epidemiology of Genital Human Papillomavirus Infection
Koutsky, P. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,107
Winer, R. L. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf180 · Cited by 1,044
American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer
Saslow, D., Runowicz, C. D., Solomon, D., Moscicki, A.-B., Smith, R. A., Eyre, H. J., & Cohen, C. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.342 · Cited by 927
Sexual behaviour in Britain: Partnerships, practices, and HIV risk behaviours.
Johnson, A. M., Mercer, C. H., Erens, B., Copas, A. J., McManus, S., Wellings, K., Fenton, K. A., Korovessis, C., Macdowall, W., Nanchahal, K., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06883-0 · Cited by 815
Villa, L. L., Costa, R. L. R., Petta, C. A., Andrade, R. P., Paavonen, J., Iversen, O.-E., Olsson, S.-E., Høye, J., Steinwall, M., Riis-Johannessen, G., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603469 · Cited by 806
Self-citationPersistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia
Ho, G. Y. F., Burk, R. D., Klein, S., Kadish, A. S., Chang, C. J., Palan, P., Basu, J., Tachezy, R., Lewis, R., & Romney, S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.18.1365 · Cited by 803
Swan, J., Breen, N., Coates, R. J., Rimer, B. K., & Lee, N. C. (2003) · Cancer · doi:10.1002/cncr.11208 · Cited by 767
Smith, H. O., Tiffany, M. F., Qualls, C. R., & Key, C. R. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5826 · Cited by 736
Condom Use and the Risk of Genital Human Papillomavirus Infection in Young Women
Winer, R. L., Hughes, J. P., Feng, Q., O'Reilly, S., Kiviat, N. B., Holmes, K. K., & Koutsky, L. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053284 · Cited by 694
Sexual Behavior and Selected Health Measures: Men and Women 15-44 Years of Age, United States, 2002
Mosher, W. D., Chandra, A., & Jones, J. (2005) · PsycEXTRA Dataset · doi:10.1037/e609202007-001 · Cited by 693
Castellsagué, X., Díaz, M., de Sanjosé, S., Muñoz, N., Herrero, R., Franceschi, S., Peeling, R. W., Ashley, R., Smith, J. S., Snijders, P. J. F., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj067 · Cited by 688
The epidemiology of genital human papillomavirus infection
Trottier, H., & Franco, E. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.054 · Cited by 686
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682
Sexual Practices, Sexually Transmitted Diseases, and the Incidence of Anal Cancer
Daling, J. R., Weiss, N. S., Hislop, T. G., Maden, C., Coates, R. J., Sherman, K. J., Ashley, R. L., Beagrie, M., Ryan, J. A., & Corey, L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710153171601 · Cited by 665
Franco, E. L., Villa, L. L., Sobrinho, J. P., Prado, J. M., Rousseau, M., Désy, M., & Rohan, T. E. (1999) · The Journal of Infectious Diseases · doi:10.1086/315086 · Cited by 657
Johnson, L. G., Madeleine, M. M., Newcomer, L. M., Schwartz, S. M., & Daling, J. R. (2004) · Cancer · doi:10.1002/cncr.20364 · Cited by 641
Prevalence of HPV Infection among Men: A Systematic Review of the Literature
Dunne, E. F., Nielson, C. M., Stone, K. M., Markowitz, L. E., & Giuliano, A. R. (2006) · The Journal of Infectious Diseases · doi:10.1086/507432 · Cited by 615
Castellsague, X., & Munoz, N. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003477 · Cited by 606
Ault, K. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60852-6 · Cited by 590
Immune responses to human papillomavirus
Stanley, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.002 · Cited by 586
Joura, E. A., Leodolter, S., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Koutsky, L. A., Garland, S. M., Harper, D. M., Tang, G. W., Ferris, D. G., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60777-6 · Cited by 581
Self-citationAbma, J. C., Martinez, G. M., Mosher, W. D., & Dawson, B. S. (2004) · PsycEXTRA Dataset · doi:10.1037/e609162007-001 · Cited by 576
Carter, J. J., Koutsky, L. A., Hughes, J. P., Lee, S. K., Kuypers, J., Kiviat, N., & Galloway, D. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315498 · Cited by 575
Moscicki, A.-B., Shiboski, S., Broering, J., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R., Kanowitz, S., Miller, S. B., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70445-7 · Cited by 564
Moscicki, A.-B. (2001) · JAMA · doi:10.1001/jama.285.23.2995 · Cited by 557
Human Papillomavirus Infection in Women Infected with the Human Immunodeficiency Virus
Sun, X.-W., Kuhn, L., Ellerbrock, T. V., Chiasson, M. A., Bush, T. J., & Wright, T. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371903 · Cited by 543
Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
Goldie, S. J., Kohli, M., Grima, D., Weinstein, M. C., Wright, T. C., Bosch, F. X., & Franco, E. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh104 · Cited by 539
Model for Assessing Human Papillomavirus Vaccination Strategies
Elbasha, E. H., Dasbach, E. J., & Insinga, R. P. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1301.060438 · Cited by 491
Block, S. L., Nolan, T., Sattler, C., Barr, E., Giacoletti, K. E. D., Marchant, C. D., Castellsagué, X., Rusche, S. A., Lukac, S., Bryan, J. T., et al. (2006) · Pediatrics · doi:10.1542/peds.2006-0461 · Cited by 484
Self-citationMyers, E. R., McCrory, D. C., Nanda, K., Bastian, L., & Matchar, D. B. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010166 · Cited by 470
Trends in the Incidence of Invasive and In Situ Vulvar Carcinoma
Judson, P. L., Habermann, E. B., Baxter, N. N., Durham, S. B., & Virnig, B. A. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000210268.57527.a1 · Cited by 469
Villa, L. L., Ault, K. A., Giuliano, A. R., Costa, R. L. R., Petta, C. A., Andrade, R. P., Brown, D. R., Ferenczy, A., Harper, D. M., Koutsky, L. A., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.068 · Cited by 469
Self-citationOlsson, S.-E., Villa, L. L., Costa, R. L. R., Petta, C. A., Andrade, R. P., Malm, C., Iversen, O.-E., Høye, J., Steinwall, M., Riis-Johannessen, G., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.03.049 · Cited by 454
Self-citationMao, C., Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Wiley, D. J., Alvarez, F. B., Bautista, O. M., Jansen, K. U., & Barr, E. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000192397.41191.fb · Cited by 451
Self-citationThe Estimated Direct Medical Cost of Sexually Transmitted Diseases Among American Youth, 2000
Chesson, H. W., Blandford, J. M., Gift, T. L., Tao, G., & Irwin, K. L. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3601104 · Cited by 444
(ALTS) Group, T. A. S. C. O. U. S. /.-G. S. I. L. T. S. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.5.397 · Cited by 438
Development and Duration of Human Papillomavirus Lesions, after Initial Infection
Winer, R. L., Kiviat, N. B., Hughes, J. P., Adam, D. E., Lee, S., Kuypers, J. M., & Koutsky, L. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/427557 · Cited by 417
The Vaccine Adverse Event Reporting System (VAERS)
(1994) · Vaccine · doi:10.1016/0264-410x(94)90044-2 · Cited by 392
Leyden, W. A., Manos, M. M., Geiger, A. M., Weinmann, S., Mouchawar, J., Bischoff, K., Yood, M. U., Gilbert, J., & Taplin, S. H. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji115 · Cited by 387
Evaluating Human Papillomavirus Vaccination Programs
Taira, A. V., Neukermans, C. P., & Sanders, G. D. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1011.040222 · Cited by 379
Herrero, R., Castle, P. E., Schiffman, M., Bratti, M. C., Hildesheim, A., Morales, J., Alfaro, M., Sherman, M. E., Wacholder, S., Chen, S., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428850 · Cited by 377
Duensing, S., & Münger, K. (2004) · International Journal of Cancer · doi:10.1002/ijc.11691 · Cited by 366
External Genital Warts: Diagnosis, Treatment, and Prevention
Wiley, D. J., Douglas, J., Beutner, K., Cox, T., Fife, K., Moscicki, A., & Fukumoto, L. (2002) · Clinical Infectious Diseases · doi:10.1086/342109 · Cited by 354
A Population-Based Study of Squamous Cell Vaginal Cancer: HPV and Cofactors
Daling, J. R., Madeleine, M. M., Schwartz, S. M., Shera, K. A., Carter, J. J., McKnight, B., Porter, P. L., Galloway, D. A., McDougall, J. K., & Tamimi, H. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2001.6502 · Cited by 346
van Seters, M., van Beurden, M., & de Craen, A. J. M. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.02.012 · Cited by 338
Schlecht, N. F. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg037 · Cited by 338
Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs
Kulasingam, S. L. (2003) · JAMA · doi:10.1001/jama.290.6.781 · Cited by 337
Carter, J. J., Koutsky, L. A., Wipf, G. C., Christensen, N. D., Lee, S.-K., Kuypers, J., Kiviat, N., & Galloway, D. A. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.927 · Cited by 326
Ley, C., Bauer, H. M., Reingold, A., Schiffman, M. H., Chambers, J. C., Tashiro, C. J., & Manos, M. M. (1991) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/83.14.997 · Cited by 320
Molano, M. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg171 · Cited by 315
Cost Effectiveness of a Potential Vaccine for Human papillomavirus
Sanders, G. D., & Taira, A. V. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0901.020168 · Cited by 310
The Burden of Illness of Cancer: Economic Cost and Quality of Life
Brown, M. L., Lipscomb, J., & Snyder, C. (2001) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.22.1.91 · Cited by 309
Reisinger, K. S., Block, S. L., Lazcano-Ponce, E., Samakoses, R., Esser, M. T., Erick, J., Puchalski, D., Giacoletti, K. E. D., Sings, H. L., Lukac, S., et al. (2007) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000253970.29190.5a · Cited by 296
Self-citationBarnabas, R. V., Laukkanen, P., Koskela, P., Kontula, O., Lehtinen, M., & Garnett, G. P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030138 · Cited by 293
Partial characterization of viral DNA from human genital warts (condylomata acuminata)
Gissmann, L., & Hausen, H. Z. (1980) · International Journal of Cancer · doi:10.1002/ijc.2910250509 · Cited by 276
Opalka, D., Lachman, C. E., MacMullen, S. A., Jansen, K. U., Smith, J. F., Chirmule, N., & Esser, M. T. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.1.108-115.2003 · Cited by 276
Vulvar Intraepithelial Neoplasia: Aspects of the Natural History and Outcome in 405 Women
Jones, R. W., Rowan, D. M., & Stewart, A. W. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187301.76283.7f · Cited by 273
Greer, C. E., Wheeler, C. M., Ladner, M. B., Beutner, K., Coyne, M. Y., Liang, H., Langenberg, A., Yen, T. S., & Ralston, R. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.8.2058-2063.1995 · Cited by 269
Anal Cancer Incidence: Genital Warts, Anal Fissure or Fistula, Hemorrhoids, and Smoking
Holly, E. A., Whittemore, A. S., Aston, D. A., Ahn, D. K., Nickoloff, B. J., & Kristiansen, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.22.1726 · Cited by 262
Chapter 12: Prophylactic HPV vaccines: Underlying mechanisms
Stanley, M., Lowy, D. R., & Frazer, I. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.110 · Cited by 262
Evaluation of Genital Sites and Sampling Techniques for Detection of Human Papillomavirus DNA in Men
Weaver, B. A., Feng, Q., Holmes, K. K., Kiviat, N., Lee, S., Meyer, C., Stern, M., & Koutsky, L. A. (2004) · The Journal of Infectious Diseases · doi:10.1086/381395 · Cited by 253
Determinants of Genital Human Papillomavirus Detection in a US Population
Peyton, C. L., Gravitt, P. E., Hunt, W. C., Hundley, R. S., Zhao, M., Apple, R. J., & Wheeler, C. M. (2001) · The Journal of Infectious Diseases · doi:10.1086/320696 · Cited by 252
Partridge, J. M., Hughes, J. P., Feng, Q., Winer, R. L., Weaver, B. A., Xi, L., Stern, M. E., Lee, S., O’Reilly, S. F., Hawes, S. E., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/521192 · Cited by 248
Dias, D., Van Doren, J., Schlottmann, S., Kelly, S., Puchalski, D., Ruiz, W., Boerckel, P., Kessler, J., Antonello, J. M., Green, T., et al. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.8.959-969.2005 · Cited by 241
Self-citationTrends in Squamous Cell Carcinoma of the Vulva: The Influence of Vulvar Intraepithelial Neoplasia
JONES, R., BARANYAI, J., & STABLES, S. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00298-6 · Cited by 234
BURK, R. D., KELLY, P., FELDMAN, J., BROMBERG, J., VERMUND, S. H., DEHOVITZ, J. A., & LANDESMAN, S. H. (1996) · Sexually Transmitted Diseases · doi:10.1097/00007435-199607000-00013 · Cited by 227
Seroprevalence of Human Papillomavirus Type 16 Infection in the United States
Stone, K. M., Karem, K. L., Sternberg, M. R., McQuillan, G. M., Poon, A. D., Unger, E. R., & Reeves, W. C. (2002) · The Journal of Infectious Diseases · doi:10.1086/344354 · Cited by 222
National Registry for Juvenile-Onset Recurrent Respiratory Papillomatosis
Reeves, W. C., Ruparelia, S. S., Swanson, K. I., Derkay, C. S., Marcus, A., & Unger, E. R. (2003) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archotol.129.9.976 · Cited by 218
Efficacy and other milestones for human papillomavirus vaccine introduction
Pagliusi, S. R., & Aguado, M. T. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.07.046 · Cited by 216
Insinga, R. P., Dasbach, E. J., & Myers, E. R. (2003) · Clinical Infectious Diseases · doi:10.1086/375074 · Cited by 216
Insinga, R. P., Dasbach, E. J., & Elbasha, E. H. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523110-00004 · Cited by 195
Natural History of Human Papillomavirus Type 16 Virus-Like Particle Antibodies in Young Women
Ho, G. Y. F., Studentsov, Y. Y., Bierman, R., & Burk, R. D. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-03-0191 · Cited by 195
Collins, S. (2002) · BJOG: An International Journal of Obstetrics and Gynaecology · doi:10.1016/s1470-0328(02)01053-4 · Cited by 183
Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England
Sasieni, P., & Adams, J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04646-8 · Cited by 176
Cancer Incidence in Kentucky, Pennsylvania, and West Virginia: Disparities in Appalachia
Lengerich, E. J., Tucker, T. C., Powell, R. K., Colsher, P., Lehman, E., Ward, A. J., Siedlecki, J. C., & Wyatt, S. W. (2005) · The Journal of Rural Health · doi:10.1111/j.1748-0361.2005.tb00060.x · Cited by 175
Jansen, K. U., Rosolowsky, M., Schultz, L. D., Markus, H. Z., Cook, J. C., Donnelly, J. J., Martinez, D., Ellis, R. W., & Shaw, A. R. (1995) · Vaccine · doi:10.1016/0264-410x(95)00103-8 · Cited by 164
Low risk of perinatal transmission of human papillomavirus: Results from a prospective cohort study
Heather Watts, D., Koutsky, L. A., Holmes, K. K., Goldman, D., Kuypers, J., Kiviat, N. B., & Galloway, D. A. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)80027-6 · Cited by 158
Manhart, L. E., Holmes, K. K., Koutsky, L. A., Wood, T., Kenney, D. L., Feng, Q., & Kiviat, N. B. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000204545.89516.0a · Cited by 156
Youth Risk Behavior Surveillance — United States, 2003 (Abridged)
Grunbaum, J. A., Kann, L. K., Kinchen, S., Ross, J. G., Hawkins, J., Lowry, R., Harris, W. A., McManus, T., Chyen, D., & Collins, J. L. (2004) · Journal of School Health · doi:10.1111/j.1746-1561.2004.tb06620.x · Cited by 146
Human Papillomavirus Genotypes and the Cumulative 2‐Year Risk of Cervical Precancer
Wheeler, C. M., Hunt, W. C., SCHIFFMAN, M. H., Castle, P. E., & Atypical Squamous Cells of Undetermined Significance/Low‐Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group (2006) · The Journal of Infectious Diseases · doi:10.1086/507909 · Cited by 145
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Cervical Cancer Incidence in a Prevaccine Era in the United States, 1998–2002
Saraiya, M., Ahmed, F., Krishnan, S., Richards, T. B., Unger, E. R., & Lawson, H. W. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000254165.92653.e8 · Cited by 140
Antibodies from Women Immunized with Gardasil ® Cross-Neutralize HPV 45 Pseudovirions
Smith, J. F., Brownlow, M., Brown, M. J., Kowalski, R., Esser, M. T., Ruiz, W., Barr, E., Brown, D. R., & Bryan, J. T. (2007) · Human Vaccines · doi:10.4161/hv.3.4.4058 · Cited by 137
Self-citationThe health care costs of cervical human papillomavirus–related disease
Insinga, R. P., Glass, A. G., & Rush, B. B. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.01.042 · Cited by 137
Human Papillomavirus Infection in Men Attending a Sexually Transmitted Disease Clinic
Baldwin, S. B., Wallace, D. R., Papenfuss, M. R., Abrahamsen, M. E., Vaught, L., Kornegay, J. R., Hallum, J. A., Redmond, S. A., & Giuliano, A. R. (2003) · The Journal of Infectious Diseases · doi:10.1086/368220 · Cited by 133
Lifetime Number of Partners As the Only Independent Risk Factor for Human Papillomavirus Infection
KARLSSON, R., Jönsson, M., Edlund, K., Evander, M., GUSTAVSSON, Å., BODÉN, E., Rylander, E., & Wadell, G. (1995) · Sexually Transmitted Diseases · doi:10.1097/00007435-199503000-00008 · Cited by 118
Management of anogenital warts (condylomata acuminata).
von Krogh, G. (2001) · PubMed · Cited by 105
Increased Incidence of Cancer among Homosexual Men, New York City and San Francisco, 1978-1990
Koblin, B. A., Hessol, N. A., Zauber, A. G., Taylor, P. E., Buchbinder, S., Katz, M. H., & Stevens, C. E. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008861 · Cited by 102
Genital human papillomavirus infection in women who have sex with women: A review
Marrazzo, J. M., Stine, K., & Koutsky, L. A. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106681 · Cited by 99
Human Papillomavirus Vaccines and Prevention of Cervical Cancer
Jansen, K. U., & SHAW, A. R. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103520 · Cited by 78
Hernandez, B. Y., McDuffie, K., Goodman, M. T., Wilkens, L. R., Thompson, P. J., Zhu, X., Wong, W., & Ning, L. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.513-517.2006 · Cited by 63
PATHOGENESIS AND TREATMENT OF JUVENILE ONSET RECURRENT RESPIRATORY PAPILLOMATOSIS
Green, G. E., Bauman, N. M., & Smith, R. J. (2000) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(05)70215-2 · Cited by 62
RECURRENT RESPIRATORY PAPILLOMATOSIS OF THE LARYNX
Derkay, C. S., & Darrow, D. H. (2000) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(05)70270-x · Cited by 49
Pagliusi, S. R., Dillner, J., Pawlita, M., Quint, W. G. V., Wheeler, C. M., & Ferguson, M. A. J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.016 · Cited by 44
Zelmanowicz, A. D. M., SCHIFFMAN, M. H., Herrero, R., Goldstein, A. M., Sherman, M. E., Burk, R. D., Gravitt, P. E., Viscidi, R. P., Schwartz, P. E., Barnes, W. A., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21048 · Cited by 39
Hand-genital transmission of genital warts? An analysis of prevalence data
Fairley, C. K., Gay, N., Forbes, A. B., Abramson, M. J., & Garland, S. M. (1995) · Epidemiology and Infection · doi:10.1017/s0950268800058234 · Cited by 39
EPIDEMIOLOGY OF GENITAL HUMAN PAPILLOMAVIRUS
Tortolero‐Luna, G. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70163-5 · Cited by 30
Goodman, A. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30275-8 · Cited by 30
Etiology and Prevention of Cervical Adenocarcinomas
Hildesheim, A., & de González, A. B. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj098 · Cited by 25
Management of Women With Cervical Cytology Interpreted as ASC-US or as ASC-H
Cox, J. T. (2005) · Clinical Obstetrics & Gynecology · doi:10.1097/01.grf.0000151571.91814.f3 · Cited by 24
JUVENILE LARYNGEAL PAPILLOMATOSIS IN A PEDIATRIC POPULATION: A Clinicopathologic Study
Somers, G. R., Tabrizi, S. N., Borg, A. J., Garland, S. M., & Chow, C. W. (1997) · Pediatric Pathology & Laboratory Medicine · doi:10.1080/107710497175029 · Cited by 11
Cited by
Predictors of HPV vaccine acceptability: A theory-informed, systematic review
Brewer, N. T., & Fazekas, K. I. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2007.05.013 · Cited by 862
The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States
Chesson, H. W., Dunne, E. F., Hariri, S., & Markowitz, L. E. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000193 · Cited by 706
Garland, S. M., Steben, M., Sings, H. L., James, M., Lu, S., Railkar, R., Barr, E., Haupt, R. M., & Joura, E. A. (2009) · The Journal of Infectious Diseases · doi:10.1086/597071 · Cited by 532
Self-citationEvidence-based clinical guidelines for immigrants and refugees
Pottie, K., Greenaway, C., Feightner, J., Welch, V., Swinkels, H., Rashid, M., Narasiah, L., Kirmayer, L. J., Ueffing, E., MacDonald, N. E., et al. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.090313 · Cited by 526
Markowitz, L. E., Hariri, S., Lin, C., Dunne, E. F., Steinau, M., McQuillan, G., & Unger, E. R. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit192 · Cited by 521
Metadata
- Authors
- Gellin, B., Modlin, J. F., Barr, E., & Tamms, G.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-09-01
- Volume
- 45
- Issue
- 5
- Pages
- 609-617
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2115532578
- Cited by
- 330
- References
- 125
- FWCI
- 24.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.